Hyloris Pharmaceuticals SA's total assets for Q2 2025 were €37.05M, a decrease of 0.00% from the previous quarter. DE:52U total liabilities were €8.16M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.